Aging Grants Under Review: NIH Hybrid Meeting Set
Published Date: 12/22/2025
Notice
Summary
The National Institute on Aging is holding a hybrid meeting on March 30-31, 2026, to review research labs and principal investigators (PIs). Some parts of the meeting will be open to the public, while others will be closed to protect privacy. This meeting affects researchers seeking grants and helps decide who gets funding and support.
Analyzed Economic Effects
2 provisions identified: 1 benefits, 0 costs, 1 mixed.
NIA Will Review Individual Grant Applications
The National Institute on Aging will hold a hybrid meeting on March 30-31, 2026, to review, discuss, and evaluate individual grant applications and the qualifications and performance of principal investigators (PIs). Parts of the meeting will be closed under 5 U.S.C. 552b(c)(4) and (c)(6) to protect personal privacy while those reviews are conducted.
Public Access Rules and Visitor Security
The open portions of the meeting on March 30-31, 2026 are available to the public with attendance limited to space available and registration is not required. In-person visitors must follow NIH security procedures (show one form of ID such as a driver's license or passport and accept vehicle inspections), and people needing accommodations (for example, sign language interpretation) should notify the listed contact person in advance.
Your PRIA Score
Personalized for You
How does this regulation affect your finances?
Sign up for a PRIA Policy Scan to see your personalized alignment score for this federal register document and every other regulation we track. We analyze your financial profile against policy provisions to show you exactly what matters to your wallet.
Key Dates
Department and Agencies
Related Federal Register Documents
2026-06501 — Government-Owned Inventions; Availability for Licensing
The National Institutes of Health is offering a cool new invention—special human antibodies that can fight certain cancers and autoimmune diseases—for companies to license and develop into treatments. This means businesses can jump on this opportunity to create powerful new medicines using government-backed research. Interested parties should act soon and may need to sign agreements to get full details.
2026-06283 — Prospective Grant of an Exclusive Patent License: Pigment Epithelium-Derived Factor (PEDF) Peptides and Use for Treating Retinal Degeneration
The National Eye Institute plans to give Perpetual Biosciences, Inc. an exclusive license to use special PEDF peptides to treat eye diseases that cause vision loss. This means the company will have the sole right to develop and sell this promising treatment, potentially helping millions with retinal degeneration. If you want to comment or apply for a license, act fast—submissions close April 16, 2026!
2026-05957 — Center for Scientific Review; Notice of Closed Meetings
The NIH’s Center for Scientific Review is holding several closed virtual meetings in April 2026 to review and decide on important research grant applications. These meetings affect scientists seeking funding in areas like neuroscience, cancer, and liver disease. No public access is allowed to protect private info and trade secrets, and these reviews help decide where millions in research money will go.
2026-05672 — National Institute on Deafness and Other Communication Disorders; Notice of Closed Meetings
The National Institute on Deafness and Other Communication Disorders is holding two closed meetings in late April and early May 2026 to review grant applications and evaluate researchers’ qualifications. These meetings affect scientists seeking funding and help ensure top-notch research gets supported. No public access means privacy is protected, and the process keeps the money flowing to the best projects on time.
2026-05673 — Center for Scientific Review; Notice of Closed Meetings
The Center for Scientific Review is holding several closed virtual meetings on April 17, 2026, to review and evaluate important grant applications in health and science fields. These meetings protect private info and trade secrets while deciding who gets funding. Researchers and organizations applying for grants should note these dates as they impact funding decisions but don’t involve public attendance or extra costs.
2026-05738 — Submission for OMB Review; 30-Day Comment Request; National Institutes of Health (NIH) Loan Repayment Programs, (Office of the Director)
The NIH is asking for a 30-day public comment on extending its Loan Repayment Programs that help doctors and scientists pay off their student loans while they do important health research. This extension keeps the program running smoothly with no big changes, and comments are due by April 23, 2026. If you’re a researcher with student loans, this program could save you money while you help improve health!
Previous / Next Documents
Previous: 2025-23596 — Center for Scientific Review; Amended Notice of Meeting
The Center for Scientific Review changed the leader of an important Alzheimer's research meeting from Dr. Bo-Shiun Chen to Dr. Roger Bannister. This meeting, happening on January 22, 2026, is closed to the public and won’t affect any funding or timing. Scientists involved in neurodegenerative disease research should note this leadership update.
Next: 2025-23598 — National Institute of Biomedical Imaging and Bioengineering; Notice of Closed Meeting
The National Institute of Biomedical Imaging and Bioengineering is holding a virtual meeting on January 28, 2026, to discuss important updates and review grant applications. Part of the meeting will be closed to protect private info and trade secrets. This affects researchers waiting on funding decisions and keeps the grant review process fair and secure.
Take It Personal
Get Your Personalized Policy View
Start a Free Government Policy Watch to see how policy affects your household, then upgrade to PRIA Full Coverage for year-round monitoring.
Already have an account? Sign in